DLA PIPER LLP (US) for INDIVIOR INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
H.R. 2586, Reentry Act of 2025, policies related to reimbursement of substance use disorder treatment.
Foreign entity interest: Indivior PLC, interests are those of parent company.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLE MARIE RUZINSKI BERTSCH | — |
| KARINA LYNCH | — |
| RACHEL PORTMAN | — |
Health Issues HCR
General education on issues related to the Drug Enforcement Agency (DEA). Issues related to substance use addiction and treatment, including NIH/HHS funding levels.Issues related to access to addiction treatments, including telehealth.
Foreign entity interest: Indivior PLC, interests are those of parent company.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLE MARIE RUZINSKI BERTSCH | — |
| KARINA LYNCH | — |
| RACHEL PORTMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.